Eric L. Snyder

6.0k total citations · 2 hit papers
36 papers, 3.7k citations indexed

About

Eric L. Snyder is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eric L. Snyder has authored 36 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Eric L. Snyder's work include RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (7 papers) and RNA Interference and Gene Delivery (5 papers). Eric L. Snyder is often cited by papers focused on RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (7 papers) and RNA Interference and Gene Delivery (5 papers). Eric L. Snyder collaborates with scholars based in United States, Australia and United Kingdom. Eric L. Snyder's co-authors include Steven F. Dowdy, Tyler Jacks, Michelle Becker‐Hapak, Alan L. Ho, Natalie A. Lissy, Sergei A. Ezhevsky, Hikaru Nagahara, Denise Crowley, Charles A. Whittaker and Bryan R. Meade and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Eric L. Snyder

34 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration

1998 819 citations Hikaru Nagahara, Eric L. Snyder et al. Nature Medicine profile →
Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis

2013 471 citations Eric L. Snyder, Tyler Jacks et al. Genes & Development profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric L. Snyder United States	24	2.6k	1.2k	701	510	505	36	3.7k
Vimla Band United States	31	2.8k 1.1×	1.4k 1.2×	568 0.8×	479 0.9×	260 0.5×	70	4.2k
A. Hunter Shain United States	23	2.8k 1.1×	2.1k 1.7×	1.2k 1.8×	288 0.6×	571 1.1×	36	4.6k
J. Reifenberger Germany	35	2.8k 1.1×	1.2k 1.0×	755 1.1×	781 1.5×	410 0.8×	100	4.7k
Hrvoje Miletić Norway	40	2.5k 1.0×	1.1k 0.9×	1.4k 2.1×	395 0.8×	444 0.9×	118	5.3k
Johanna Lahdenranta United States	23	2.0k 0.8×	1.4k 1.2×	618 0.9×	231 0.5×	327 0.6×	51	3.6k
Richard C. Bates United States	32	2.2k 0.8×	1.6k 1.3×	566 0.8×	268 0.5×	507 1.0×	51	4.3k
Vimla Band United States	35	2.2k 0.9×	1.7k 1.4×	648 0.9×	979 1.9×	192 0.4×	74	4.0k
David Cobrinik United States	34	3.0k 1.2×	2.5k 2.1×	590 0.8×	282 0.6×	227 0.4×	74	4.8k
Nicola Crosetto Sweden	30	3.7k 1.5×	1.0k 0.9×	1.0k 1.4×	201 0.4×	268 0.5×	72	4.6k
Branden S. Moriarity United States	29	2.5k 1.0×	1.4k 1.2×	798 1.1×	420 0.8×	209 0.4×	95	4.2k

Countries citing papers authored by Eric L. Snyder

Since Specialization

Citations

This map shows the geographic impact of Eric L. Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Snyder more than expected).

Fields of papers citing papers by Eric L. Snyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric L. Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Snyder. The network helps show where Eric L. Snyder may publish in the future.

Co-authorship network of co-authors of Eric L. Snyder

This figure shows the co-authorship network connecting the top 25 collaborators of Eric L. Snyder. A scholar is included among the top collaborators of Eric L. Snyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric L. Snyder. Eric L. Snyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stubben, Chris, et al.. (2025). Differential Control of Growth and Identity by HNF4α Isoforms in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Research. 23(11). 936–952. 1 indexed citations

Liu, Bingxin, et al.. (2025). PBAE-PEG/Lipid Nanoparticle Delivery of RNA for the Creation of Genetically Engineered Lung Cancer Mouse Models. Nano Letters. 25(51). 17578–17583.

Ghazi, Phaedra C., Mark R. Silvis, Yun Zhang, et al.. (2024). Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer. eLife. 13. 5 indexed citations

Wilson, Emily, et al.. (2024). FoxA1/2-dependent epigenomic reprogramming drives lineage switching in lung adenocarcinoma. Developmental Cell. 60(3). 472–489.e8. 7 indexed citations

Ghazi, Phaedra C., Mark R. Silvis, Yun Zhang, et al.. (2024). Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer. eLife. 13. 9 indexed citations

Zewdu, Rediet, Soledad A. Camolotto, Alex Jones, et al.. (2021). An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma. eLife. 10. 11 indexed citations

Camolotto, Soledad A., Luke A. Torre-Healy, Jeffery M. Vahrenkamp, et al.. (2020). Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4. Gut. 70(5). 900–914. 35 indexed citations

Caswell, Deborah R., Chen-Hua Chuang, K. Rosanna, et al.. (2018). Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma. Molecular Cancer Research. 16(11). 1737–1749. 35 indexed citations

Camolotto, Soledad A., Timothy L. Mosbruger, Alex Jones, et al.. (2018). FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer. eLife. 7. 53 indexed citations

10.

Camolotto, Soledad A., et al.. (2018). The role of lineage specifiers in pancreatic ductal adenocarcinoma. Journal of Gastrointestinal Oncology. 9(6). 1005–1013. 6 indexed citations

11.

Sicińska, Ewa, Jeffrey T. Czaplinski, Stephen P. Remillard, et al.. (2014). Antiproliferative Effects of CDK4/6 Inhibition in CDK4 -Amplified Human Liposarcoma In Vitro and In Vivo. Molecular Cancer Therapeutics. 13(9). 2184–2193. 98 indexed citations

12.

Watanabe, Hideo, Joshua M. Francis, Michele Sue‐Ann Woo, et al.. (2013). Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes & Development. 27(2). 197–210. 53 indexed citations

13.

Winslow, Monte M., Talya L. Dayton, Roel G.W. Verhaak, et al.. (2011). Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 473(7345). 101–104. 317 indexed citations

14.

Dooley, Alison L., Monte M. Winslow, Derek Y. Chiang, et al.. (2011). Nuclear factor I/B is an oncogene in small cell lung cancer. Genes & Development. 25(14). 1470–1475. 126 indexed citations

15.

Friedlander, Sharon, Gerald C. Chu, Eric L. Snyder, et al.. (2009). Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras. Europe PMC (PubMed Central). 249 indexed citations

16.

Snyder, Eric L., Kenneth Law, Christopher Fiore, et al.. (2009). c‐Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme. The Journal of Pathology. 218(3). 292–300. 65 indexed citations

17.

Snyder, Eric L. & Steven F. Dowdy. (2005). Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids invivo. Expert Opinion on Drug Delivery. 2(1). 43–51. 78 indexed citations

18.

Snyder, Eric L., Bryan R. Meade, Cheryl Saenz, & Steven F. Dowdy. (2004). Treatment of Terminal Peritoneal Carcinomatosis by a Transducible p53-Activating Peptide. PLoS Biology. 2(2). e36–e36. 157 indexed citations

19.

Bollag, Brigitte, Cindy Prins, Eric L. Snyder, & Richard J. Frisque. (2000). Purified JC Virus T and T′ Proteins Differentially Interact with the Retinoblastoma Family of Tumor Suppressor Proteins. Virology. 274(1). 165–178. 68 indexed citations

20.

Nagahara, Hikaru, Eric L. Snyder, Alan L. Ho, et al.. (1998). Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nature Medicine. 4(12). 1449–1452. 819 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact